A comparison of quality of abstracts of systematic reviews including meta-analysis of randomized controlled trials in high-impact general medicine journals before and after the publication of PRISMA extension for abstracts: A systematic review and meta-analysis

被引:33
|
作者
Bigna J.J.R. [1 ]
Um L.N. [2 ]
Nansseu J.R.N. [2 ,3 ]
机构
[1] Centre Pasteur of Cameroon, Department of Epidemiology and Public Health, Yaoundé
[2] University of Yaoundé I, Faculty of Medicine and Biomedical Sciences, Yaoundé
[3] Mother and Child Centre of the Chantal Biya Foundation, Sickle Cell Disease Unit, Yaoundé
关键词
Abstract; General medicine journal; Meta-analysis; PRISMA; Randomized controlled trial; Systematic review;
D O I
10.1186/s13643-016-0356-8
中图分类号
学科分类号
摘要
Background: Journal abstracts including those reporting systematic reviews (SR) should contain sufficiently clear and accurate information for adequate comprehension and interpretation. The aim was to compare the quality of reporting of abstracts of SRs including meta-analysis published in high-impact general medicine journals before and after publication of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for abstracts (PRISMA-A) released in April 2013. Methods: SRs including meta-analysis of randomized controlled trials published in 2012, 2014, and 2015 in top-tier general medicine journals were searched in PubMed. Data was selected and extracted by two reviewers based on the PRISMA-A guidelines which recommend to include 12 items. The primary outcome was the adjusted mean number of items reported; the secondary outcome was the reporting of each item and factors associated with a better reporting. Adjustment was made for abstract word count and format, number of authors, PRISMA endorsement, and publication on behalf of a group. Results: We included 84 abstracts from 2012, 59 from 2014, and 61 from 2015. The mean number of items reported in 2015 (7.5; standard deviation [SD] 1.6) and in 2014 (6.8; SD 1.6) differed and did not differ from that reported in 2012 (7.2; SD 1.7), respectively; adjusted mean difference: 0.9 (95 % CI 0.4; 1.3) and -0.1 (95 % CI -0.6; 0.4). From 2012 to 2014, the quality of reporting was in regression for "strengths and limitations of evidence" and "funding"; contrariwise, it remained unchanged for the others items. Between 2012 and 2015, the quality of reporting rose up for "description of the effect", "synthesis of results", "interpretation", and "registration"; but decreased for "strengths and limitations of evidence"; it remained unchanged for the other items. The overall better reporting was associated with abstracts structured in the 8-headings format in 2014 and abstracts with a word count <300 in 2014 and 2015. Conclusions: Not surprisingly, the quality of reporting did not improve in 2014 and suboptimally improved in 2015. There is still room for improvement to meet the standards of PRISMA-A guidelines. Stricter adherence to these guidelines by authors, reviewers, and journal editors is highly warranted and will surely contribute to a better reporting. © 2016 The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Zhu, Gui-Qi
    Zou, Zhuo-Lin
    Zheng, Ji-Na
    Chen, Da-Zhi
    Zou, Tian-Tian
    Shi, Ke-Qing
    Zheng, Ming-Hua
    [J]. MEDICINE, 2016, 95 (09)
  • [2] Systematic Review, Meta-Analysis and Randomized Controlled Trials in Cytopathology
    AbdullGaffar, Badr
    [J]. ACTA CYTOLOGICA, 2012, 56 (03) : 221 - 227
  • [3] injury: A systematic review and meta-analysis of randomized controlled trials
    Daou, Marietou
    Dionne, Joanna C.
    Teng, Jennifer F. T.
    Taran, Shaurya
    Zytaruk, Nicole
    Cook, Deborah
    Wilcox, M. Elizabeth
    [J]. JOURNAL OF CRITICAL CARE, 2022, 71
  • [4] Chinese herbal medicine for headache: A systematic review and meta-analysis of high-quality randomized controlled trials
    Shi, Yi-Hua
    Wang, Yong
    Fu, Huan
    Xu, Zhen
    Zeng, Hua
    Zheng, Guo-Qing
    [J]. PHYTOMEDICINE, 2019, 57 : 315 - 330
  • [5] A systematic review and meta-analysis of randomized trials
    Jaaback, Kenneth
    [J]. INTRAPERITONEAL CANCER THERAPY, 2007, : 31 - 44
  • [6] Comparison of the recovery quality between remimazolam and propofol after general anesthesia: systematic review and a meta-analysis of randomized controlled trials
    Zhu, Caiyun
    Xie, Ran
    Qin, Fang
    Wang, Naiguo
    Tang, Hui
    [J]. PEERJ, 2024, 12
  • [7] Systematic Review/Meta-analysis Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Samuel, Michelle
    Tardif, Jean-Claude
    Bouabdallaoui, Nadia
    Khairy, Paul
    Dube, Marie-Pierre
    Blondeau, Lucie
    Guertin, Marie-Claude
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (05) : 776 - 785
  • [8] Traditional Chinese medicine for smoking cessation: An umbrella review of systematic reviews and meta-analysis of randomized controlled trials
    Lu, Chun -Li
    Jin, Xin-Yan
    Wang, Qian-Yun
    Chen, Xiao-Ying
    Zheng, Ruo-Xiang
    Wang, Chao-Jie
    Jiang, Jing-Jing
    Qiao, Shu-Yu
    Yang, Si -Hong
    Zhang, Wei -Han
    Chen, Si-Yi
    Li, Jia-Xuan
    Liu, Xue-Han
    Suo, Yu-Si
    Wang, Jian-Hua
    Xue, Xue
    Liang, Li-Rong
    Robinson, Nicola
    Liu, Jian-Ping
    [J]. TOBACCO INDUCED DISEASES, 2023, 21
  • [9] Chinese patent medicine for atherosclerosis: a systematic review and Meta-analysis of randomized controlled trials
    XU Jian
    LIU Yuntao
    LUO Zhihao
    ZHAO Zhen
    WANG Dawei
    LIU Qing
    [J]. Journal of Traditional Chinese Medicine., 2024, 44 (06) - 1090
  • [10] Herbal Medicine Treatment for Influenza: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Choi, Minhyung
    Lee, Sun Haeng
    Chang, Gyu Tae
    [J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 2020, 48 (07): : 1553 - 1576